Gie Ken‐Dror
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Corneal surgery and disorders
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Genetics 5
- Genetic Associations and Epidemiology 5
- Co-authors
- Yaniv Barkana (1 shared paper)David Zadok (1 shared paper)Shulamit Schwartz (1 shared paper)Isaac Avni (1 shared paper)Uri Elbaz (1 shared paper)Yariv Gerber (1 shared paper)Steve E. Humphries (8 shared papers)Philippa J. Talmud (5 shared papers)
- Journals
- Malaria Journal (2 papers)Molecular Medicine (2 papers)European Journal of Epidemiology (1 paper)Andrology (1 paper)Trials (1 paper)
- Partner nations
- United KingdomIsraelUnited States
In The Last Decade
Gie Ken‐Dror
35 papers receiving 768 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 107
- Radiology, Nuclear Medicine and Imaging 182
- Ophthalmology 52
- Endocrinology, Diabetes and Metabolism 89
- Internal Medicine 16
Countries citing papers authored by Gie Ken‐Dror
This map shows the geographic impact of Gie Ken‐Dror's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gie Ken‐Dror with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gie Ken‐Dror more than expected).
Fields of papers citing papers by Gie Ken‐Dror
This network shows the impact of papers produced by Gie Ken‐Dror. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gie Ken‐Dror. The network helps show where Gie Ken‐Dror may publish in the future.
Co-authors
The 25 scholars most cited alongside Gie Ken‐Dror, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 259 | |
| 2 | 2006 | 126 | |
| 3 | 2010 | 44 | |
| 4 | 2010 | 44 | |
| 5 | 2010 | 26 | |
| 6 | 2017 | 23 | |
| 7 | 2013 | 21 | |
| 8 | 2022 | 20 | |
| 9 | 2013 | 19 | |
| 10 | 2010 | 19 | |
| 11 | 2010 | 18 | |
| 12 | 2020 | 16 | |
| 13 | 2021 | 15 | |
| 14 | 2010 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2012 | 11 | |
| 17 | 2011 | 11 | |
| 18 | 2023 | 10 | |
| 19 | 2018 | 9 | |
| 20 | [Development of a Hebrew questionnaire to be used in epidemiological studies to assess physical fitness--validation against sub maximal stress test and predicted VO2max]. | 2004 | 9 |
About Gie Ken‐Dror
Gie Ken‐Dror is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Infectious Diseases, Molecular Biology and Surgery, having authored 37 papers that have together received 790 indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cerebral Venous Sinus Thrombosis (3 papers), Blood properties and coagulation (3 papers), Obstructive Sleep Apnea Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Tuberculosis Research and Epidemiology (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Pharmacology (107 citations), Radiology, Nuclear Medicine and Imaging (182 citations), Ophthalmology (52 citations), Endocrinology, Diabetes and Metabolism (89 citations) and Internal Medicine (16 citations). Gie Ken‐Dror has collaborated with scholars based in United Kingdom, Israel and United States. Frequent co-authors include Yaniv Barkana, David Zadok, Shulamit Schwartz, Isaac Avni, Uri Elbaz, Yariv Gerber, Steve E. Humphries, Philippa J. Talmud, Fotios Drenos and Pankaj Sharma. Their work appears in journals such as Malaria Journal, Molecular Medicine, European Journal of Epidemiology, Andrology and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.